Tom Kline named co-liaison counsel for Risperdal cases
Tom Kline has been named co-liaison counsel by the Court of Common Pleas for Philadelphia for the coordinated litigation involving the drug Risperdal. The anti-psychotic pharmaceutical has been linked to abnormal breast growth in males, including children, adolescents and adults, a condition called gynocomastia. The coordinated litigation in Philadelphia includes about 400 cases. Kline & […]
Tom Kline named co-liaison counsel for Risperdal cases Read More »